Press Release
Global QuantiFERON-TB Gold Test Market Set to Surpass USD 1.2 Billion by 2032
Pune, December 5, 2025 – Global Data Route Analytics
The global QuantiFERON-TB Gold Test Market is witnessing a significant growth trajectory, with its value estimated at USD 684 million in 2024 and projected to reach approximately USD 1.26 billion by 2032, expanding at a steady CAGR of nearly 7.9%. This surge is driven by the heightened focus on early and accurate diagnosis of latent tuberculosis infection (LTBI), especially in high-risk population clusters worldwide.
For a free sample of the report, please contact us here
https://globaldatarouteanalytics.com/report/225/global-quantiferon-tb-gold-test-market/download
The market's momentum is further fueled by the growing preference for blood-based TB tests over traditional skin testing, driven by technological advancements in IGRA (Interferon-Gamma Release Assay) platforms. These innovations enable more accurate, single-visit diagnosis—especially beneficial in resource-limited and high-burden regions. The QuantiFERON-TB Gold Plus Test (QFT-Plus) is rapidly gaining adoption due to its clinical reliability and ease of use.
Additionally, global health policies and government initiatives supporting TB eradication, coupled with strategic partnerships with diagnostic laboratories, are strengthening the market landscape. The continued prevalence of TB in emerging economies also positions this diagnostic segment for long-term demand.
For any inquiry related to this report, please click here
https://globaldatarouteanalytics.com/report/225/global-quantiferon-tb-gold-test-market/inquiry
Market Segmentation – Global QuantiFERON-TB Gold Test Market
• By Test Type
• QuantiFERON-TB Gold In-Tube Test (QFT-GIT)
• QuantiFERON-TB Gold Plus Test (QFT-Plus)
• By Application
• Latent Tuberculosis Infection (LTBI) Detection
• Active Tuberculosis Detection
• By End User
• Hospitals
• Diagnostic Laboratories
• Clinics
• Research Institutes
• By Region
• North America (United States, Canada)
• Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe)
• Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of Asia-Pacific)
• Latin America (Brazil, Mexico, Rest of Latin America)
• Middle East and Africa (UAE, Saudi Arabia, South Africa, Rest of MEA)
Key Players
• Qiagen N.V.
• Hologic, Inc.
• Abbott Laboratories
• Thermo Fisher Scientific Inc.
• Bio-Rad Laboratories, Inc.
• Meridian Bioscience, Inc.
• Oxford Immunotec Global PLC
• Cellestis Limited (Qiagen Company)
• Dynex Technologies, Inc.
For discounts related to this report, explore here
https://globaldatarouteanalytics.com/report/225/global-quantiferon-tb-gold-test-market/discount
About the company
Global Data Route Analytics is a market research and consulting firm that provides businesses with data analysis, market forecasts, and tailored reports across various industries. The company uses advanced data analysis techniques, proprietary data, and an expert team to help clients understand market trends, make informed decisions, and develop strategies. They focus on delivering customized solutions, competitive intelligence, and growth strategies to help businesses succeed in their respective markets.
Media Contact:
Srushti Tungar
Global Data Route Analytics
